JSW Group to procure vaccines for 25,000 employees and their families
ECONOMY & POLICY

JSW Group to procure vaccines for 25,000 employees and their families

As an initial step in the process of inoculating employees against Covid-19, JSW Group, a few Tata Group companies, the India unit of a major multinational, and numerous other firms have plans to begin talks with vaccine manufacturers. The employees working at manufacturing units are more vulnerable than those working from home, and will receive priority treatment.

The first shots of the vaccine will be available from as early as March. According to sources, around two to three lakh doses will be supplied. Serum Institute of India began delivering its Covishield vaccines last week, followed by Bharat Biotech with the homegrown Covaxin. The initial focus is to vaccinate healthcare and frontline professionals by July.

Tata Group said that some of the companies in the conglomerate have initiated discussions on procuring vaccines, but a decision hasn't been taken yet, as informed by sources.

The India unit of a multinational manufacturing company is awaiting communication from the parent, which has initiated talks with global vaccine manufacturers for its units in North America and Europe.

Instead of depending on Serum Institute and Bharat Biotech alone, companies are waiting for more vaccines to come into the market. Four other companies are in different stages of conducting trials including Russia's Sputnik vaccine that will be distributed by Dr Reddy's Lab in India, and Zydus Cadila, which recently got the nod for third phase trials.

As companies await better clarity on the supply of vaccines, some wonder whether vaccination of employees could be included under corporate social responsibility.

Image source

As an initial step in the process of inoculating employees against Covid-19, JSW Group, a few Tata Group companies, the India unit of a major multinational, and numerous other firms have plans to begin talks with vaccine manufacturers. The employees working at manufacturing units are more vulnerable than those working from home, and will receive priority treatment. The first shots of the vaccine will be available from as early as March. According to sources, around two to three lakh doses will be supplied. Serum Institute of India began delivering its Covishield vaccines last week, followed by Bharat Biotech with the homegrown Covaxin. The initial focus is to vaccinate healthcare and frontline professionals by July. Tata Group said that some of the companies in the conglomerate have initiated discussions on procuring vaccines, but a decision hasn't been taken yet, as informed by sources. The India unit of a multinational manufacturing company is awaiting communication from the parent, which has initiated talks with global vaccine manufacturers for its units in North America and Europe. Instead of depending on Serum Institute and Bharat Biotech alone, companies are waiting for more vaccines to come into the market. Four other companies are in different stages of conducting trials including Russia's Sputnik vaccine that will be distributed by Dr Reddy's Lab in India, and Zydus Cadila, which recently got the nod for third phase trials. As companies await better clarity on the supply of vaccines, some wonder whether vaccination of employees could be included under corporate social responsibility. Image source

Next Story
Real Estate

Dharavi Rising

Dharavi, Asia’s largest informal settlement, stands on the cusp of a historic transformation. With an ambitious urban renewal project finally taking shape, millions of residents are looking ahead with hope. But delivering a project of this scale brings immense challenges – from land acquisition to rehabilitate ineligible residents outside Dharavi and rehabilitation to infrastructure development. It also requires balancing commercial goals with deep-rooted social impact. At the helm is SVR Srinivas, IAS, CEO & Officer on Special Duty, Dharavi Redevelopment Project (DRP), Government..

Next Story
Real Estate

MLDL Records 20.4% Growth in Pre-Sales

Mahindra Lifespace Developers Limited (MLDL), the real estate and infrastructure development arm of the Mahindra Group, announced its financial results for the quarter ended March 31, 2025. In line with INDAS 115, the company recognises revenues using the completion of contract method. Key highlights FY25: Consolidated sales (Residential and IC&IC) of Rs 32.99 billion. Gross development value (GDV) additions in FY25 were Rs 1.81 trillion compared to Rs 440 billion in FY24 (~4x growth). Residential pre-sales of Rs 28.04 billion in FY25, reflecting 20.4% growth o..

Next Story
Infrastructure Transport

UCSL Delivers India's First Green Cargo Vessel to Norway

In a landmark achievement for Indian shipbuilding and the Atma Nirbhar Bharat initiative, Udupi Cochin Shipyard Limited (UCSL), a subsidiary of Cochin Shipyard Limited (CSL), has delivered the first of six next-generation green cargo vessels to Norway-based Wilson Ship Management AS, Europe’s largest short-sea shipping operator. The 3,800 DWT vessel, named Wilson Eco 1, was handed over during a ceremony at New Mangalore Port. The delivery is part of a Rs 5.06 billion project supported by Norway’s green maritime funding programme, marking India's entry into the European eco-friendly ca..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?